Menus Subscribe Search

Class of Antipsychotics Ineffective in PTSD Treatment

• August 10, 2011 • 4:00 AM

The future may hold a drug therapy for treating post-traumatic stress disorder, but some of the popular choices of the last few years, like Risperdal, won’t be part of it.

A new era of psychopharmacology combined with two wars in Asia has created its own surge in treating combat stress with prescription drugs. For tough cases doctors have even prescribed antipsychotics. But all drugs are not created equal, and a new study claims that one class of antipsychotic is no better than a placebo for treating post-traumatic stress.

The study underlines that there is no drug for PTSD symptoms. The researchers concentrated on one medication, Risperdal, but the results may apply to a whole class of antipsychotics that work on neurotransmission in the brain.

“It definitely calls into question the use of anti-psychotics in general for PTSD,” Charles Hoge, a senior scientist at the Walter Reed Army Institute of Research, told The New York Times.

Antipsychotics like Risperdal target the way brain cells handle neurotransmitters like serotonin and dopamine. In that sense they’re similar to antidepressants. They ease a symptom that might correspond to PTSD, but recent research indicates that combat stress can cause physical damage to the brain. The cells themselves may have changed shape or started to work in a different way.

Basically, antipsychotics may affect the brain on too shallow a level to help. But there might be hope for drugs that try to fix cells on a level closer to a person’s genes.

“We don’t understand the disorder well enough. All we have are puzzle pieces,” says Dr. Ulrike Schmidt, a PTSD expert at the Max Planck Institute for Psychiatry in Munich. “But I can imagine that with more high-throughput experiments we will identify target genes, or the proteins they produce, which we can then try to steer with pharmaceuticals.”

Her opinion is that the right genes or proteins might be found roughly “in the household of stress hormones,” like cortisol.

Schmidt’s research has shown that PTSD causes semi-permanent damage not only to parts of the brain, but also to the epigenome, the complex of molecules that surrounds a person’s DNA and influences which genes are expressed. It’s like a blow to a person’s firmware — damage to a system that tells the body what to do. It’s not irreversible, though a predisposition for it could be passed on to another generation.

Antipsychotics — widely prescribed as they are — may seem off the mark because psychosis itself is not a typical outcome of post-traumatic stress (the way depression is). But symptoms of psychosis and PTSD can overlap. And doctors have been prescribing antipsychotics “based almost entirely on their experience with them and how they expect them to work,” according to the Times. [class name="dont_print_this"]

European Dispatch

EUROPEAN DISPATCH
Michael Scott Moore complements his standing feature in Miller-McCune magazine with frequent posts on the policy challenges and solutions popping up on the other side of the pond.

[/class]

The big caveat is that PTSD isn’t well understood. And some vets may have been prone to certain psychoses to start with. The current study didn’t select for them.

This research into molecules and brain behavior may wind up emphasizing that PTSD is too fine-grained and changeable to be treated entirely with drugs. As a disorder it seems to straddle the mysterious boundary between the mind and the brain. The simplest treatment — for most people — may still be sports, like surfing or biking, combined with talk therapy.

Schmidt helps run a clinic in Munich for people with severe post-traumatic stress, where the treatment involves drugs as well as therapy. “We have psychotherapy that includes depth psychology, gestalt therapy and behavioral-therapy elements. We never say, ‘Only behavioral therapy is good’ — we combine them. And we try to ease certain symptoms with medication. For example, a patient with severe sleeping problems might receive medication for that. … But the big goal is to lighten the therapy, or speed it up, with a PTSD-specific medication.”

One other non-pharmacological treatment, of course, would be to fight fewer wars.

Sign up for the free Miller-McCune.com e-newsletter.

“Like” Miller-McCune on Facebook.

Follow Miller-McCune on Twitter.

Add Miller-McCune.com news to your site.

Subscribe to Miller-McCune

Michael Scott Moore
Michael Scott Moore was a 2006-2007 Fulbright fellow for journalism in Germany, and The Economist named his surf travelogue, "Sweetness and Blood," a book of the year in 2010. His first novel, "Too Much of Nothing," was published by Carroll & Graf in 2003, and he’s written about politics and travel for The Atlantic Monthly, Slate, the Los Angeles Times, and Spiegel Online in Berlin, where he serves as editor-at-large.

More From Michael Scott Moore

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

September 17 • 4:00 AM

The Strong Symbolic Power of Emptying Pockets

Israeli researchers find the symbolic act of emptying a receptacle can impact our behavior, and not for the better.


September 16 • 4:00 PM

Why Is LiveJournal Helping Russia Block a Prominent Critic of Vladimir Putin?

The U.S. blogging company is showing an error message to users inside Russia who try to read the blog of Alexei Navalny, a prominent politician and critic of the Russian government.


September 16 • 2:00 PM

Man Up, Ladies! … But Not Too Much

Too often, women are asked to display masculine traits in order to be successful in the workplace.



September 16 • 12:00 PM

What Makes You So Smart, Brilliant 12-Year-Old?

Charles Wang is going to rule the world.


September 16 • 10:09 AM

No Innovation Without Migration: The Harlem Renaissance

The Harlem Renaissance wasn’t a place, but an era of migration. It would have happened even without New York City.


September 16 • 10:00 AM

A Law Professor Walks Into a Creative Writing Workshop

One academic makes the case for learning how to write.



September 16 • 7:23 AM

Does Not Checking Your Buddy’s Facebook Updates Make You a Bad Friend?

An etiquette expert, a social scientist, and an old pal of mine ponder the ever-shifting rules of friendship.



September 16 • 6:12 AM

3-D Movies Aren’t That Special

Psychologists find that 3-D doesn’t have any extra emotional impact.


September 16 • 6:00 AM

What Color Is Your Pygmy Goat?

The fierce battle over genetic purity, writ small. Very small.



September 15 • 4:00 PM

The Average Prisoner Is Visited Only Twice While Incarcerated

And black prisoners receive even fewer visitors.


September 15 • 2:00 PM

Gambling With America’s Health

The public health costs of legal gambling.


September 15 • 12:23 PM

The Scent of a Conservative

We are attracted to the body odor of others with similar political beliefs, according to new research.


September 15 • 12:00 PM

2014: A Pretty Average Election

Don’t get too worked up over this year’s congressional mid-terms.


September 15 • 10:00 AM

Online Harassment of Women Isn’t Just a Gamer Problem

By blaming specific subcultures, we ignore a much larger and more troubling social pathology.


September 15 • 8:00 AM

Atheists Seen as a Threat to Moral Values

New research attempts to pinpoint why non-believers are widely disliked and distrusted.


September 15 • 6:12 AM

To Protect Against Meltdowns, Banks Must Map Financial Interconnections

A new model suggests looking beyond balance sheets, studying the network of investment as well.


September 15 • 6:00 AM

Interview With a Drug Dealer

What happens when the illicit product you’ve made your living off of finally becomes legal?


September 15 • 4:00 AM

A Feeling of Control: How America Can Finally Learn to Deal With Its Impulses

The ability to delay gratification has been held up as the one character trait to rule them all—the key to academic success, financial security, and social well-being. But willpower isn’t the answer. The new, emotional science of self-regulation.



September 15 • 2:04 AM

No Innovation Without Migration: Do Places Make People?

We know that people make places, but does it also work the other way?


September 12 • 4:00 PM

Life, Liberty, and the Pursuit of Plastic Bags

California wants you to pay for your plastic bags. (FYI: That’s not an infringement on your constitutional rights.)


Follow us


3-D Movies Aren’t That Special

Psychologists find that 3-D doesn't have any extra emotional impact.

To Protect Against Meltdowns, Banks Must Map Financial Interconnections

A new model suggests looking beyond balance sheets, studying the network of investment as well.

Big Government, Happy Citizens?

You may like to talk about how much happier you'd be if the government didn't interfere with your life, but that's not what the research shows.

Give Yourself a Present for the Future

Psychologists discover that we underestimate the value of looking back.

In Soccer as in Art, Motifs Matter

A new study suggests a way to quantitatively measure a team’s style through its pass flow. It may become another metric used to evaluate potential recruits.

The Big One

One in three drivers in Brooklyn's Park Slope—at certain times of day—is just looking for parking. The same goes for drivers in Manhattan's SoHo. September/October 2014 new-big-one-3

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.